MARC Record from marc_columbia

LEADER: 05015cam a22004574a 4500
001 6858948
005 20221122053744.0
008 080410t20082008dcua b 001 0 eng
010 $a 2008016646
015 $aGBA894747$2bnb
016 7 $a101471209$2DNLM
016 7 $a014681230$2Uk
020 $a9781555814038
020 $a1555814034
029 1 $aNLM$b101471209
035 $a(OCoLC)ocn225388570
035 $a(OCoLC)225388570
035 $a(NNC)6858948
035 $a6858948
040 $aDNLM/DLC$cDLC$dNLM$dYDXCP$dBTCTA$dC#P$dUKM$dCDX$dOrLoB-B
042 $apcc
050 00 $aRM666.P835$bT54 2008
060 10 $aQU 145.5$bT398 2008
082 00 $a615/.329$222
245 00 $aTherapeutic microbiology :$bprobiotics and related strategies /$cedited by James Versalovic, Michael Wilson.
260 $aWashington, DC :$bASM Press,$c[2008], ©2008.
300 $axvi, 403 pages :$billustrations ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tIntroduction -- $g1.$tIntroduction /$rMary Ellen Sanders -- $g2.$tBasic Biology -- $g2.1.$tThe Indigenous Microbiota -- $g2.$tRole of the Indigenous Microbiota in Health and Disease /$rGerald W. Tannock -- $g2.2.$tBiology of Effector Organisms for Probiotic and Replacement Therapy -- $g3.$tLactobacilli /$rCovadonga Barbes -- $g4.$tBifidobacteria: the Model Human Gut Commensal /$rMarco Ventura, Francesca Turroni, Angela Ribbera, Elena Foroni and Douwe van Sinderen -- $g5.$tSaccharomyces spp. /$rXinhua Chen and Ciaran P. Kelly -- $g6.$tStreptococci as Effector Organisms for Probiotic and Replacement Therapy /$rJohn R. Tagg, Jeremy P. Burton, Philip A. Wescombe and Chris N. Chilcott -- $g7.$tEscherichia coli /$rMichael Schultz -- $g8.$tFormulation, Administration, and Delivery of Probiotics /$rKasipathy Kailasapathy -- $g2.3.$tPrebiotics and Functional Carbohydrates -- $g9.$tIntroduction to Prebiotics /$rHelena M. R. T. Parracho, Delphine M. Saulnier, Anne L. McCartney and Glenn R. Gibson -- $g10.$tHuman Milk Oligosaccharides as Prebiotics /$rGiovanni V. Coppa and Orazio Gabrielli -- $g11.$tInulin-Type Fructans /$rJan Van Loo and Douwina Bosscher -- $g12.$tResistant Starch as a Prebiotic /$rAnthony R. Bird and David L. Topping -- $g13.$tEffects of Prebiotic Supplementation on Bone Mineral Metabolism and Weight in Humans /$rSteven A. Abrams -- $g14.$tPrebiotics and Lipid Metabolism /$rNathalie M. Delzenne, Patrice D. Cani and Audrey M. Neyrinck -- $g2.4.$tGenomics of Lactic Acid Bacteria -- $g15.$tFunctional Genomics of Lactic Acid Bacteria /$rTri Duong and Todd R. Klaenhammer -- $g2.5.$tProteomics of Lactic Acid Bacteria -- $g16.$tProteomic Approaches To Study Lactic Acid Bacteria /$rDavid P. A. Cohen, Elaine E. Vaughan, Willem M. de Vos and Erwin G. Zoetendal -- $g3.$tTherapeutic Microbiology in Human Medicine -- $g3.1.$tProbiotics -- $g17.$tProbiotics in Human Medicine: Overview /$rJennifer K. Spinler and James Versalovic -- $g18.$tProbiotics and Other Organisms in Allergy and Autoimmune Diseases /$rG. A. W. Rook and N. Witt -- $g19.$tProbiotics in Oral Biology and Dentistry /$rJ. H. Meurman -- $g20.$tProbiotics in Gastrointestinal Diseases /$rFrancisco Guarner -- $g21.$tProbiotics and Diseases of the Genitourinary Tract /$rGregor Reid -- $g22.$tProbiotics in Neurology and Psychiatry /$rPaul Forsythe and John Bienenstock -- $g3.2.$tPrebiotics -- $g23.$tPrebiotics in Human Medicine /$rIan Rowland -- $g3.3.$tSynbiotics -- $g24.$tSynbiotics in Human Medicine /$rStig Bengmark -- $g4.$tTherapeutic Microbiology in Veterinary Medicine -- $g25.$tStrategies for Altering the Intestinal Microbiota of Animals /$rSergey R. Konstantinov and Jerry Wells -- $g26.$tProbiotics in Veterinary Medicine /$rJ. Scott Weese, Shayan Sharif and Alex Rodriguez-Palacios -- $g27.$tPrebiotics and Synbiotics in Companion Animal Science /$rDavid Hernot, Eva Ogue, George Fahey and Robert A. Rastall -- $g5.$tViral Strategies -- $g28.$tPhage Therapy /$rMikael Skurnik, Saija Kiljunen and Maria Pajunen -- $g6.$tFuture Prospects -- $g29.$tThe Road Ahead: a Look at the Future /$rJames Versalovic and Michael Wilson.
650 0 $aProbiotics.$0http://id.loc.gov/authorities/subjects/sh2006003499
650 0 $aMicroorganisms$xTherapeutic use.
650 12 $aProbiotics$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D019936Q000627
650 22 $aGastrointestinal Diseases$xprevention & control.$0https://id.nlm.nih.gov/mesh/D005767Q000517
650 22 $aGastrointestinal Diseases$xtherapy.$0https://id.nlm.nih.gov/mesh/D005767Q000628
650 22 $aIntestines$ximmunology.$0https://id.nlm.nih.gov/mesh/D007422Q000276
650 22 $aIntestines$xmicrobiology.$0https://id.nlm.nih.gov/mesh/D007422Q000382
700 1 $aVersalovic, James.$0http://id.loc.gov/authorities/names/n2008181702
700 1 $aWilson, Michael,$d1947 April 12-$0http://id.loc.gov/authorities/names/nb99100585
852 00 $boff,hsl$hRM666.P835$iT54 2008 Q